United States Patent 8,888,745 (US8888745): Scope, Claim Boundaries, and US Landscape
US8888745 is directed to an implant insertion system for placing a rod-like, drug-containing implant under the skin using a retractable cannula and a user-grippable handle that is geometrically related to the cannula (cantilevered, spaced, substantially parallel along at least most of the exposed insertion length). The patent also covers specific sub-architectures for cannula/rod sliding actuation and lever-based securing/release of the implant, and it includes method and product-by-process style “in combination” claim formats tied to progestogenic implants (including etonogestrel) and stated implant dimensions.
What does US8888745 claim, in plain functional terms?
Core construct (recurring across independent claim 1 and key dependents)
At the applicator level, the patent repeatedly requires these elements:
- Housing plus cannula with an insertion length that extends outside the housing.
- Rod that is extendable inside the cannula.
- Handle for grasping and maneuvering the applicator during insertion.
- A handle-forming geometry:
- Cantilevered portion of the housing over the cannula
- The cantilevered handle portion extends along and in spaced, substantially parallel relation to the cannula’s exposed insertion length.
- The cantilevered portion has a width perpendicular to the insertion length that is substantially larger than the cannula diameter so a user can grip it.
- The cantilevered portion’s width increases along the insertion length to form respective side surfaces.
- Retractability mechanism:
- The cannula is retractable into the housing by sliding the cannula relative to the rod for expelling the implant.
Coverage-expanding variants
US8888745 then broadens or narrows scope through additional required structural and positional limitations, including:
- Handle extent: handle portion extends along at least 30% of the exposed cannula insertion length (dependent claim 2).
- Handle profile: a top surface raised relative to other housing features (dependent claim 3).
- Actuator integration:
- Claim 4 adds a cannula holder, a rod mounted on/in the housing, and an actuator that slides cannula and rod relative to each other.
- The actuator is located on the cantilevered handle portion and moves relative to it.
- Claim 5 specifies actuator position when an implant is present (over the cannula).
- Claims 6 and 7 specify flexible interconnection between actuator and holder and retention in guides.
- Lever-based implant securing/release:
- Claim 8 introduces a lever extending along part of the cannula, rotatable/slidable/flexible between:
- first position: implant secured in cannula/cannula holder
- second position: implant no longer secured
- Claim 9 adds that in the first position the lever at least partially covers the cannula.
“In combination” product scope (implant + applicator)
The patent also claims combinations where:
- The implant is elongate rod-like and contains active substance (claim 10).
- The handle extends parallel and spaced from at least 80% of the entire cannula length outside the housing (claim 10).
- Side surfaces enable grip; handle stiffness greater than cannula (claims 11-12).
- The implant is secured against accidental removal prior to use, including by a protrusion in the cannula that releases when the cannula is inserted under the skin (claims 13-14).
- Drug specificity appears in claim 17 (progestogenic hormone), and claim 19 gives etonogestrel with 40 mm length and 2 mm diameter.
Specific contraceptive implantation architecture (claim 18 and claim 20)
Claim 18 is a dedicated framing for inserting a rod-like contraceptive implant containing a progestogenic hormone with:
- retractable, movable cannula relative to housing,
- an implant retained in the cannula prior to use,
- a rod expelling the implant when cannula retracts,
- and a handle that extends along and is spaced from at least part of the exposed cannula insertion length.
Claim 20 adds more “mechanical design” features:
- housing has distal/proximal ends and a hollow interior,
- cannula extends from housing interior at an intermediate position toward the distal end,
- a rod extends into the cannula,
- cannula slidable relative to rod for expelling,
- handle portion is on the housing between intermediate and distal end, and
- handle side surfaces have a width perpendicular to the cannula insertion length that is substantially larger than cannula diameter.
How broad are the independent claims vs. the narrow mechanical limitations?
Independent claim 1: apparatus with specific handle-cannula geometry and sliding cannula/rod expulsion
Claim 1 is broad on the functional relationship (retractable cannula via sliding relative to a rod for expelling) but narrow on:
- Cantilevered housing portion over the cannula
- Spaced, substantially parallel extension along the exposed insertion length
- Width growth along insertion length to form side surfaces
- Width perpendicular to insertion length substantially larger than cannula diameter
- Cantilevered portion extends along in spaced parallel relation to at least part of exposed insertion length
This geometry is the key claim-defining feature likely to drive design-around.
Independent claim 4: adds actuator and holder interactions with flexible element
Claim 4 is dependent-like in that it reuses the core cantilever/parallel handle construct but adds a more specific actuation architecture:
- Cannula holder proximal end of cannula, slidable over the rod
- Actuator for sliding cannula and rod relative to each other
- Actuator located on the cantilevered handle portion
- Actuator moves with respect to the cantilevered handle portion
- Actuator and holder interconnected by a flexible element (claims 6-7)
This shifts scope from “any retraction mechanism” to a constrained mechanical system.
Independent claim 10: combination tied to handle extent and implant being drug-loaded rod
Claim 10 does not require the “width increasing along the insertion length” language seen in claim 1. Instead it requires:
- handle portion extends along and spaced from at least 80% of the cannula length outside the housing
- handle portion has width substantially greater than cannula thickness (grippable)
- implant is an elongate rod-like element containing active substance
That makes claim 10 potentially broader on handle cross-section evolution but still specific on handle extent.
Independent claim 18: contraceptive-specific framing
Claim 18 narrows the drug content to progestogenic hormone implants and keeps broad mechanical features (housing, movable retractable cannula, rod expelling, handle spaced from exposed cannula length). It is broad on the mechanical actuation style relative to claim 4 (does not recite the actuator on the cantilever handle in the claim text you provided for claim 18).
What design elements are most likely to determine infringement outcomes?
1) Cantilevered housing forming a grippable handle over the cannula
The claims consistently require that at least a portion of the housing is cantilevered over the cannula to form the handle, positioned in spaced, substantially parallel relation to the exposed insertion length. A competitor handle that is not “cantilevered over” the cannula, is not “spaced,” or is not “substantially parallel” for most or all of the exposed insertion length is at risk of missing essential claim elements.
2) Width geometry that enables grip (and in claim 1, width increasing along the insertion length)
Claim 1 has a specific geometry: width perpendicular to the insertion length is substantially larger than cannula diameter, and in at least part of the cantilevered portion the width increases along the insertion length to form side surfaces. That can be a design-around target by:
- using a handle of more uniform width,
- relocating grip geometry not “along the insertion length,” or
- changing the spatial relationship relative to the cannula.
3) “Sliding cannula relative to the rod” for expelling the implant
The patent ties retraction and expulsion to a relative sliding motion between cannula and rod. Systems where implant expulsion is driven by rod advancement with cannula fixed (or driven by a different relative motion) may fall outside this language.
4) Implant securing/release features (protrusion; lever positions)
Claims 13-14 and 8-9 create additional infringement hooks if a competing device uses:
- a cannula luminal protrusion to retain the implant until cannula insertion,
- a lever that covers the cannula in a first position.
What is the claimed implant drug scope and where does it tighten?
Broad drug class
- Claim 17: active substance is a progestogenic hormone.
- Claim 18: implant contains a progestogenic hormone (contraceptive framing).
Specific drug and dimensions
- Claim 19: implant contains etonogestrel, measuring 40 mm length and 2 mm diameter.
A device using a different progestin may still fall within the progestogenic claims, but the etonogestrel-specific claim 19 requires that exact drug identity and those dimensions (as written).
How does US8888745 fit within the broader US contraceptive implant applicator landscape?
US8888745 is part of a US family space where contraceptive rod implants (including etonogestrel and similar progestins) are combined with mechanical insertion devices. The patent’s distinctiveness is not the mere presence of an inserter, but the specific handle-cannula geometry (cantilevered, spaced, substantially parallel, grippable width, handle length coverage) plus a sliding cannula relative to rod expulsion mechanism.
Practical landscape implications for R&D and IP strategy
- If your inserter uses a retracting cannula with rod-driven implant expulsion, you likely overlap on the “relative motion” concept.
- If your inserter uses a cantilevered handle geometry over the cannula with substantial handle length coverage, you likely overlap strongly with claim 1/10/20 style elements.
- If your inserter does not use a cantilevered housing over the cannula, your design is more likely to avoid the strongest geometric claim anchor.
Claim-by-claim scope map (what each claim adds beyond the base concept)
| Claim |
Adds/limits |
Impact on scope |
| 1 |
Cantilevered housing over cannula forming handle; spaced, substantially parallel along exposed insertion length; width increases along insertion length to form side surfaces; width perpendicular substantially larger than cannula diameter; cannula retracts into housing by sliding cannula relative to rod for expelling |
Core infringement driver; most geometric and mechanical constraints |
| 2 |
Handle extends along at least 30% of exposed insertion length |
Narrows to longer handle coverage |
| 3 |
Raised top surface of handle relative to rest of housing |
Limits to handle profile/geometry |
| 4 |
Cannula holder + rod + actuator; actuator located on cantilevered handle portion and movable relative to it; sliding cannula relative to rod |
Adds specific actuation architecture |
| 5 |
Actuator located over cannula when implant present |
Limits actuator positioning |
| 6 |
Cannula holder proximal slidable over rod; actuator and holder interconnected by flexible element |
Narrows actuation transmission |
| 7 |
Flexible element partially retained by guides |
Further mechanical limitation |
| 8 |
Lever along part of cannula; rotatable/slidable/flexible between implant-secured and implant-released positions |
Adds implant retention/release mechanism |
| 9 |
In first lever position, lever at least partially covers cannula |
Ties retention position to cannula coverage |
| 10 |
Combination: implant + applicator; handle portion extends along and spaced from at least 80% of entire cannula length outside housing; grippable width greater than cannula thickness |
In combination and handle coverage quantification |
| 11 |
Handle side surfaces enabling grip |
Further supports grippability but likely met by most designs |
| 12 |
Handle bending stiffness greater than cannula |
Material/stiffness limitation |
| 13 |
Prior to use, implant secured against accidental removal |
Requires retention feature at rest |
| 14 |
Secured by protrusion into cannula; release upon cannula insertion under skin |
Specific retention-release mechanism |
| 15 |
Combination adds cannula holder + rod + actuator for sliding |
Narrows to specific architecture |
| 16 |
Holder proximal slidable over rod; actuator and holder interconnected by flexible element |
Narrows to flexible actuation linkage |
| 17 |
Active substance is progestogenic hormone |
Drug class limiting |
| 18 |
Applicator for progestogenic hormone contraceptive rod implant; retractable cannula; implant retained prior to use; rod expels; handle extends along and spaced from exposed insertion length |
Drug + combination of broad mechanical concepts |
| 19 |
Etonogestrel; 40 mm x 2 mm |
Tight, drug and dimension specific |
| 20 |
Housing structure; cannula extends from intermediate position toward distal end; rod extendable into cannula; handle between intermediate and distal; width perpendicular larger than cannula diameter |
Adds detailed structural location constraints |
What does this mean for a patent landscape view (freedom-to-operate focus)?
High-risk overlap zones (elements to audit in competitors)
A competitor inserter is most likely to collide with US8888745 if it includes:
- A cantilevered housing handle over the cannula with spaced, substantially parallel alignment along the exposed insertion length.
- A handle width perpendicular to insertion length that is substantially larger than the cannula diameter and, for claim 1, increases along the insertion length.
- Cannula retraction accomplished by sliding cannula relative to the rod to expel the implant.
- For product claims: an implant that is a progestogenic hormone rod, including etonogestrel (40 mm x 2 mm) if claim 19 is asserted.
Lower-risk zones (elements that can move a design outside claim boundaries)
- A handle that is not part of a cantilevered housing portion over the cannula.
- A handle that is not spaced and substantially parallel along most/all of the exposed insertion length.
- Expulsion mechanisms where the implant is expelled by a different relative motion that does not fit “cannula retractable by sliding relative to the rod for expelling.”
Key Takeaways
- US8888745’s claim center of gravity is the inserter geometry: a cantilevered, spaced, substantially parallel handle formed by the housing over the cannula, with grippable width constraints and, in claim 1, width increasing along the insertion length.
- Mechanical expulsion is claim-anchored to cannula retraction via relative sliding between cannula and rod.
- Drug scope tightens at the combination layer: general progestogenic hormone coverage appears in claims 17 and 18, while etonogestrel 40 mm x 2 mm is explicitly claimed in claim 19.
- Design-around attention should focus on the handle-cannula spatial/structural relationship and the relative sliding expulsion mechanism, then secondarily on retention/release sub-mechanisms (protrusion and/or lever).
FAQs
1) What part of US8888745 is most likely to be the dominant infringement driver?
The combination of a cantilevered housing handle over the cannula with spaced, substantially parallel alignment along the exposed insertion length, plus the retracting cannula via sliding relative to the rod for implant expulsion (claim 1; also reflected through combination claims).
2) Does US8888745 require etonogestrel to be implicated?
No. Etonogestrel is specified in claim 19, but broader claims cover progestogenic hormone implants (claims 17 and 18, and combination formats that require an active substance/progestogenic hormone).
3) Can a competitor avoid US8888745 by using a different handle shape?
The strongest risk is changing the handle so it is not a cantilevered housing portion over the cannula, is not spaced and substantially parallel along the exposed insertion length, or does not meet the grippable width constraints. Those are key structural claim elements.
4) What retention/release features appear in US8888745?
A lever that secures/releases the implant (claims 8-9) and an alternative securing mechanism using a protrusion extending into the cannula that releases upon skin insertion (claims 13-14).
5) Does US8888745 claim a specific implant size only for etonogestrel?
Yes. The explicit numeric dimensions (40 mm length and 2 mm diameter) are tied to etonogestrel in claim 19.
References
[1] United States Patent US 8,888,745, “Applicator for inserting an implant under the skin,” claims provided in prompt.
